Hydroxyurea for Sickle Cell Disease: Now Is the Time!

被引：2

作者：

Strouse, John J. ^{[1
]}

机构：

[1] Duke Univ, Sch Med, Div Hematol, 315 Trent Dr,Suite 267, Durham, NC 27710 USA

来源：

SOUTHERN MEDICAL JOURNAL | 2016年 / 109卷 / 09期

关键词：

CONTROLLED-TRIAL; CHILDREN; ANEMIA; IMPACT; MORBIDITY; BARRIERS; ADULTS;

D O I：

10.14423/SMJ.0000000000000515

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：535 / 537

页数：3

共 24 条

[1] HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease [J].

Bolanos-Meade, Javier ;

Fuchs, Ephraim J. ;

Luznik, Leo ;

Lanzkron, Sophie M. ;

Gamper, Christopher J. ;

Jones, Richard J. ;

Brodsky, Robert A. .

BLOOD, 2012, 120 (22) :4285-4291

[2] Hydroxyurea in children with sickle cell disease: Practice patterns and barriers to utilization [J].

Brandow, Amanda M. ;

Jirovec, Danielle L. ;

Panepinto, Julie A. .

AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (08) :611-613

[3] EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA [J].

CHARACHE, S ;

TERRIN, ML ;

MOORE, RD ;

DOVER, GJ ;

BARTON, FB ;

ECKERT, SV ;

MCMAHON, RP ;

BONDS, DR ;

ORRINGER, E ;

JONES, S ;

STRAYHORN, D ;

ROSSE, W ;

PHILLIPS, G ;

PEACE, D ;

JOHNSONTELFAIR, A ;

MILNER, P ;

KUTLAR, A ;

TRACY, A ;

BALLAS, SK ;

ALLEN, GE ;

MOSHANG, J ;

SCOTT, B ;

STEINBERG, M ;

ANDERSON, A ;

SABAHI, V ;

PEGELOW, C ;

TEMPLE, D ;

CASE, E ;

HARRELL, R ;

CHILDERIE, S ;

EMBURY, S ;

SCHMIDT, B ;

DAVIES, D ;

KOSHY, M ;

TALISCHYZAHED, N ;

DORN, L ;

PENDARVIS, G ;

MCGEE, M ;

TELFER, M ;

DAVIS, A ;

CASTRO, O ;

FINKE, H ;

PERLIN, E ;

SITEMAN, J ;

GASCON, P ;

DIPAOLO, P ;

GARGIULO, S ;

ECKMAN, J ;

BAILEY, JH ;

PLATT, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1317-1322

[4]

Children's Medical Center, 2014, SICKL CELL PAT HYDR

[5]

Creary SE., 2014, AM SOC HEMATOL

[6] Hydroxyurea use in Children with Sickle Cell Disease: Do Severely Affected Patients Use It and Does It Impact Hospitalization Outcomes? [J].

Creary, Susan E. ;

Chisolm, Deena J. ;

Koch, Terah L. ;

Zigmont, Victoria A. ;

Lu, Bo ;

O'Brien, Sarah H. .

PEDIATRIC BLOOD & CANCER, 2016, 63 (05) :844-847

[7] Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia [J].

DeBaun, M. R. ;

Gordon, M. ;

McKinstry, R. C. ;

Noetzel, M. J. ;

White, D. A. ;

Sarnaik, S. A. ;

Meier, E. R. ;

Howard, T. H. ;

Majumdar, S. ;

Inusa, B. P. D. ;

Telfer, P. T. ;

Kirby-Allen, M. ;

McCavit, T. L. ;

Kamdem, A. ;

Airewele, G. ;

Woods, G. M. ;

Berman, B. ;

Panepinto, J. A. ;

Fuh, B. R. ;

Kwiatkowski, J. L. ;

King, A. A. ;

Fixler, J. M. ;

Rhodes, M. M. ;

Thompson, A. A. ;

Heiny, M. E. ;

Redding-Lallinger, R. C. ;

Kirkham, F. J. ;

Dixon, N. ;

Gonzalez, C. E. ;

Kalinyak, K. A. ;

Quinn, C. T. ;

Strouse, J. J. ;

Miller, J. P. ;

Lehmann, H. ;

Kraut, M. A. ;

Ball, W. S., Jr. ;

Hirtz, D. ;

Casella, J. F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (08) :699-710

[8]

Evidence-Based Management of Sickle Cell Disease, 2014, EXPERT PANEL REPORT

[9]

Lanzkron S, 2008, ANN INTERN MED

[10]

Lanzkron S, 2008, J NATL MED ASSOC, V100, P968

← 1 2 3 →